Crossmark

Low kidney uptake of GLP-1R-targeting, beta cell-specific PET tracer, 18F-labeled [Nle14,Lys40]exendin-4 analog, shows promise for clinical imaging

Crossref DOI link: https://doi.org/10.1186/S13550-016-0243-2

Published: 2016-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Mikkola, Kirsi

Yim, Cheng-Bin

Lehtiniemi, Paula

Kauhanen, Saila

Tarkia, Miikka

Tolvanen, Tuula

Nuutila, Pirjo

Solin, Olof
Funding

Funding for this research was provided by:

Novo Nordisk Fonden

Maud Kuistilan Muistosäätiö

BetaImage (FP7/2007-2013, grant agreement 222980)

The Finnish Diabetes Research Foundation

The Finnish Cultural Foundation

BetaCure (FP7/2014-2018, grant agreement 602812)

Finnish Centre of Excellence in Cardiovascular and Metabolic Diseases
License Information

unspecified valid from 2016-12-01